Flavonoids and alkenylbenzenes: Mechanisms of mutagenic action and carcinogenic risk

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 574, Issue 1-2 SPEC. ISS., 2005, Pages 124-138

  Rietjens, Ivonne M C M ^a   Boersma, Marelle G ^a   Van Der Woude, Hester ^a   Jeurissen, Suzanne M F ^a   Schutte, Maaike E ^a   Alink, Gerrit M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Alkenylbenzene; Flavonoid; Mutagenic action

Indexed keywords

ALKENE; BENZENE DERIVATIVE; CARCINOGEN; ESTRAGOLE; FLAVONOID; METHYLEUGENOL; QUERCETIN; QUINONE DERIVATIVE; SAFROLE;

CARCINOGENIC ACTIVITY; CARCINOGENICITY; CONFERENCE PAPER; DEGRADATION; DNA ADDUCT; DNA REPAIR; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; ISOMERIZATION; LIFESTYLE; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TOXICOKINETICS;

ALLYL COMPOUNDS; ANIMALS; ANISOLES; CARCINOGENS; EUGENOL; FLAVONOIDS; MUTAGENS; QUERCETIN; RATS; SAFROLE;

ANIMALIA;

EID: 19444377689     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.01.028     Document Type: Conference Paper

References (100)

1. E. Middleton, and C. Kandaswami The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer J.B. Harborne The Flavonoids 1994 Chapman & Hall London 619 652
2. C.A. Rice-Evans, N.J. Miller, and G. Paganga Structure-antioxidant activity relationships of flavonoids and phenolic acids Free Rad. Biol. Med. 20 1996 933 956
3. G. Block, S. Patterson, and A. Subar Fruit, vegetables and cancer prevention: a review of the epidemiological evidence Nutr. Cancer 18 1992 1 29
4. A.T. Diplock The Leon Goldberg memorial lecture: antioxidants and disease prevention Food Chem. Toxicol. 34 1996 1013 1023
5. A.T. Diplock, J.-L. Charleux, G. Crozier-Will, F.J. Kok, C. Rice-Evans, M. Roberfroid, W. Stahl, and J. Vina-Ribes Functional food science and defense against reactive oxidative species Br. J. Nutr. 80 1998 S77
6. G.S. Omenn Micronutrients (vitamins and minerals) as cancer-preventive agents IARC Sci. Publ. 139 1997 33 45
7. E.E. Deschner, J. Ruperto, G. Wong, and H.L. Newmark Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia Carcinogenesis 12 1991 1193 1196
8. G. Scambia, F.O. Ranelletti, P. Benedetti Panici, M. Piantelli, G. Bonanno, R. DeVincemo, G. Ferrandina, L. Piercelli, A. Capelli, and S. Mancuso Quercetin inhibits the growth of a multidrug resistant estrogen-receptor- negative MCF-7 human breast-cancer cell line expressing type II estrogen binding sites Cancer Chemother. Pharmacol. 28 1991 255 258
9. W.F. Matter, R.F. Brown, and C.J. Vlahos The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs Biochem. Biophys. Res. Commun. 186 1992 624 631
10. M.A. Avila, J.A. Velasco, J. Cansado, and V. Notario Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468 Cancer Res. 54 1994 2424 2428
11. G. Agullo, L. Gamet-Payrastre, S. Manenti, C. Viala, C. Rémésy, H. Chap, and B. Payrastre Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition Biochem. Pharmacol. 53 1997 1649 1657
12. S. Kameoka, P. Leavitt, C. Chang, and S.M. Kuo Expression of antioxidant proteins in human intestinal Caco-2 cells treated with dietary flavonoids Cancer Lett. 146 1999 161 167
13. R. Garcia-Closas, C.A. Gonzalez, A. Agudo, and E. Riboli Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain Cancer Causes Control 10 1999 71 75
14. D.F. Birt, S. Hendrich, and W. Wang Dietary agents in cancer prevention: flavonoids and isoflavonoids Pharmacol. Ther. 90 2001 157 177
15. M.G.L. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljkovic, M. Pekkarinen, B.S. Simic, H. Toshima, E.J.M. Feskens, P.C.H. Hollman, and M.B. Katan Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study Arch. Int. Med. 155 1995 381 386
16. J.T. MacGregor, and L. Jurd Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium Mut. Res. 54 1978 297 309
17. J.P. Brown A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds Mut. Res. 75 1980 243 277
18. M.G. Boersma, J. Vervoort, H. Szymusiak, K. Lemanska, B. Tyrakowska, N. Cenas, J. Segura-Aguilar, and I.M.C.M. Rietjens Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide Chem. Res. Toxicol. 13 2000 185 191
19. H.M. Awad, M.G. Boersma, J. Vervoort, and I.M.C.M. Rietjens Peroxidase-catalysed formation of quercetin-quinone methide glutathione adducts Arch. Biochem. Biophys. 378 2000 224 233
20. H.M. Awad, M.G. Boersma, S. Boeren, P.J. Van Bladeren, J. Vervoort, and I.M.C.M. Rietjens Structure-activity study on the quinone/quinone methide chemistry of flavonoids Chem. Res. Toxicol. 14 2001 398 408
21. G. Galati, T. Chan, B. Wu, and P.J. O'Brien Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids Chem. Res. Toxicol. 12 1999 521 525
22. H.M. Awad, M.G. Boersma, S. Boeren, H. van der Woude, J.J. van Zanden, P.J. van Bladeren, J. Vervoort, and I.M.C.M. Rietjens Identification of o-quinone/quinone methide metabolites of quercetin in a cellular in vitro system FEBS Lett. 520 2002 30 34
23. H. van der Woude, A. Gliszczynska-Swiglo, K. Struijs, A. Smeets, G.M. Alink, and I.M.C.M. Rietjens Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans Cancer Lett. 200 2003 41 47
24. T. Walle, T.S. Vincent, and U.K. Walle Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells Biochem. Pharmacol. 65 2003 1603 1610
25. H.M. Awad, M.G. Boersma, S. Boeren, P.J. Van Bladeren, J. Vervoort, and I.M.C.M. Rietjens Quenching of quercetin quinones/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation Chem. Res. Toxicol. 16 2003 822 831
26. J.C.M. Van der Hoeven, I.M. Bruggeman, and F.M.H. Debets Genotoxicity of quercetin in cultured mammalian cells Mut. Res. 136 1984 9 21
27. M. Nagao, N. Morita, T. Yahagi, M. Shimizu, M. Kuroyanagi, M. Fukuoka, K. Yoshihira, S. Natori, T. Fujino, and T. Sugimura Mutagenicities of 61 flavonoids and 11 related compounds Environ. Mut. 3 1981 401 419
28. NTP, Toxicology and carcinogenesis studies of quercetin (Cas No. 117-39-5) in F344 rats (Feed studies), NTP technical report (TR-409), NI publication No 91-3140, US Department of Health and Human Services, Public Health Service, National Toxicology Program, Research Triangle Park, NC, 1991.
29. J.K. Dunnick, and J.R. Hailey Toxicity and carcinogenicity studies of quercetin, a natural component of foods Fundam. Appl. Toxicol. 19 1992 423 431
30. A.M. Pamukcu, S. Yalciner, J.F. Hatcher, and G.T. Bryan Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum) Cancer Res. 40 1980 3468 3472
31. I. Hirono, I. Ueno, S. Hosaka, H. Takanashi, T. Matsushima, T. Sugimura, and S. Natori Carcinogenicity examination of quercetin and rutin in ACI rats Cancer Lett. 13 1981 15 21
32. K. Morino, N. Matsukura, T. Kawachi, H. Ohgaki, T. Sugimura, and I. Hirono Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration Carcinogenesis 3 1982 93 97
33. G.S. Stoewsand, J.L. Anderson, J.N. Boyd, G. Hrazdina, J.G. Babish, K.M. Walsh, and P. Losco Quercetin: a mutagen, not a carcinogen in Fisher rats J. Toxicol. Environ. Health 14 1984 105 114
34. M. Hirose, S. Fukushima, T. Sakata, M. Inui, and N. Ito Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder Cancer Lett. 21 1983 23 27
35. N. Ito, A. Hagiwara, S. Tamano, M. Kagawa, M.A. Shibata, Y. Kurata, and S. Fukushima Lack of carcinogenicity of quercetin in F334/DuCrj rats Jpn. J. Cancer Res. 80 1989 317 325
36. N. Ito Is quercetin carcinogenic? Jpn. J. Cancer Res. 83 1992 312 313
37. B.T. Zhu, E.L. Ezell, and J.G. Liehr Catechol-O-methyltransferase- catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo J. Biol. Chem. 269 1994 292 299
38. G. Williamson, A.J. Day, G.W. Plumb, and D. Couteau Human metabolic pathways of dietary flavonoids and cinnamates Biochem. Soc. Trans. 28 2000 16 22
39. B.T. Zhu, and J.G. Liehr Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estrogen-induced tumorigenesis J. Biol. Chem. 271 1996 1357 1363
40. J.L. Bolton, E. Pisha, F. Zhang, and S. Qiu Role of quinoids in estrogen carcinogenesis Chem. Res. Toxicol. 11 1998 1113 1127
41. J.L. Bolton, M.A. Trush, T.M. Penning, G. Dryhurst, and T.J. Monks Role of quinones in toxicology Chem. Res. Toxicol. 13 2000 135 160
42. J.J. van Zanden, O. Ben Hamman, M.L.P.S. van Iersel, S. Boeren, N.H.P. Cnubben, M. Lo Bello, J. Vervoort, P.J. van Bladeren, and I.M.C.M. Rietjens Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin Chem. Biol. Interact. 145 2003 139 148
43. C.J. Henderson, A.G. Smith, J. Ure, K. Brown, E.J. Bacon, and C.R. Wolf Increased skin tumorigenesis in mice lacking pi-class glutathione-S-transferases Proc. Natl. Acad. Sci. U.S.A. 95 1998 5275 5280
44. D.T. Zava, and G. Duwe Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro Nutr. Cancer 27 1997 31 40
45. C.Y. Hsieh, R.C. Santell, S.Z. Haslam, and W.G. Helferich Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo Cancer Res. 58 1998 3833 3838
46. J.M. Cline, and C.L. Hughes Jr. Phytochemicals for the prevention of breast and endometrial cancer Cancer Treat. Res. 94 1998 107 134
47. M.T. Goodman, L.R. Wilkens, J.H. Hankin, L.C. Lyu, A.H. Wu, and L.N. Kolonel Association of soy and fiber consumption with the risk of endometrial cancer Am. J. Epidemiol. 146 1997 294 306
48. E.M. Leslie, Q. Mao, C.J. Oleschuk, R.G. Deeley, and S.P. Cole Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids Mol. Pharmacol. 59 2001 1171 1180
49. J.J. van Zanden, L. Geraets, H.M. Wortelboer, P.J. van Bladeren, I.M.C.M. Rietjens, and N.H.P. Cnubben Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells Biochem. Pharmacol. 67 2004 1607 1617
50. J.J. van Zanden, H.M. Wortelboer, S. Bijlsma, A. Punt, M. Usta, P.J. van Bladeren, I.M.C.M. Rietjens, and N.H.P. Cnubben Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2 Biochem. Pharmacol. 69 2005 699 708
51. A. Di Pietro, G. Conseil, J.M. Perez-Victoria, G. Dayan, H. Baubichon-Cortay, D. Trompier, E. Steinfels, J.M. Jault, H. de Wet, M. Maitrejean, G. Comte, A. Boumendjel, A.M. Mariotte, C. Dumontet, D.B. McIntosh, A. Goffeau, S. Castanys, F. Gamarro, and D. Barron Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters Cell. Mol. Life Sci. 59 2002 307 322
52. S. Zhang, X. Yang, and M.E. Morris Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport Mol. Pharmacol. 65 2004 1208 1216
53. A.D. Mottino, T. Hoffman, L. Jennes, and M. Vore Expression and localization of multidrug resistant protein MRP2 in rat small intestine J. Pharmacol. Exp. Ther. 293 2000 717 723
54. U.K. Walle, and T. Walle Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps Carcinogenesis 20 1999 2153 2157
55. C.G. Dietrich, D.R. de Waart, R. Ottenhoff, I.G. Schoots, and R.P. Elferink Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats Mol. Pharmacol. 59 2001 974 980
56. European Commission, Opinion of the Scientific Committee on Food on Estragole (1-Allyl-4-Methoxybenzene), 2001.
57. European Commission. Opinion of the Scientific Committee on Food on Methyleugenol (4-Allyl-1,2-Dimethoxybenzene), 2001.
58. European Commission. Opinion of the Scientific Committee on Food on the safety of the presence of safrole (1-allyl-3,4-methylene dioxy benzene) in flavourings and other food ingredients with flavouring properties, 2001.
59. R.L. Smith, T.B. Adams, J. Doull, V.J. Feron, J.L. Goodman, L.J. Marnett, P.S. Portoghese, W.J. Waddell, B.M. Wagner, A.E. Rogers, J. Caldwell, and I.G. Sipes Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole Food Chem. Toxicol. 40 2002 851 870
60. N.R. Drinkwater, E.C. Miller, J.A. Miller, and H.C. Pitot Hepatocarcinogenicity of estragole and 1′-hydroxyestragole in the mouse and mutagenicity of 1′-acetoxyestragole in bacteria J. Natl. Cancer Inst. 57 1976 1323 1331
61. C. Miller, A.B. Swanson, D.H. Phillips, T.L. Fletcher, A. Liem, and J.A. Miller Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole Cancer Res. 43 1983 1124 1134
62. R.W. Wiseman, T.R. Fennel, J.A. Miller, and E.C. Miller Further characterisation of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1′-hydroxysafrole and 1′-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues Cancer Res. 45 1985 3096 3105
63. R.W. Wiseman, E.C. Miller, J.A. Miller, and A. Liem Structure-activity studies of the hepatocarcinogenicities of alkylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6JXC3H/HeJF1 mice Cancer Res. 47 1987 2275 2283
64. L. Müller, P. Kasper, K. Muller-Tegethoff, and T. Petr The genotoxic potential in vitro and in vivo of the allyl benzene etheric oils estragole, basil oil and trans-anethole Mut. Res. 325 1994 129 136
65. 32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally occurring alkenylbenzenes. I. Adult female CD-1 mice Carcinogenesis 5 1984 1613 1622
66. 32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice Carcinogenesis 5 1984 1623 1628
67. 14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers Xenobiotica 17 1987 1223 1232
68. L.V. Iyer, M.N. Ho, W.M. Shinn, W.W. Bradford, M.J. Tanga, S.S. Nath, and C.E. Green Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9 Toxicol. Sci. 73 2003 36 43
69. A. Anthony, J. Caldwell, A.J. Hutt, and R.L. Smith Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole Food Chem. Toxicol. 25 1987 799 806
70. A. Zangouras, J. Caldwell, A.J. Hutt, and R.L. Smith Dose-dependent conversion of estragole in the rat and mouse to the carcinogenic metabolite 1-hydroxyestragole Biochem. Pharmacol. 30 1981 1383 1386
71. A.B. Swanson, D.D. Chambliss, J.C. Blanquist, E.C. Miller, and J.A. Miller The mutagenicities of safrole, estragole, trans-anethole and some of their known or possible metabolites for Salmonella typhimurium mutants Mut. Res. 60 1979 143 153
72. 32P-Postlabelling analysis of adducts formed between DNA and safrole 2′,3′-epoxide: absence of adduct formation in vivo Toxicol. Lett. 75 1995 201 207
73. G. Luo, and T.M. Guenthner Covalent binding to DNA in vitro of 2′,3′-oxides derived from allylbenzene analogs Drug Metab. Dispos. 24 1996 1020 1027
74. T.M. Guenthner, and G. Luo Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs Toxicology 160 2001 47 58
75. National Toxicology Program (NTP), Toxicology and carcinogenesis studies of methyleugenol (CAS No. 93-15-12) in F344/N rats and B6C3F1 mice (gavage studies), Draft NTO-TR-491, NIH Publication No. 98-3950, 1998.
76. V.S.W. Chan, and J. Caldwell Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1′-hydroxy metabolites Food Chem. Toxicol. 30 1992 831 836
77. A.J. Howes, V.S.W. Chan, and J. Caldwell Structure-specificity of the genotoxicity of some naturally occuring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes Food Chem. Toxicol. 28 1990 537 542
78. P. Stening, I. Gardner, J.E. Kenna, M.W.H. Coughtrie, and J. Caldwell Formation of alkenylbenzene macromolecular adducts in human fibroblast V79 cells transfected with human sulfotransferases Human Exp. Toxicol. 16 1997 62
79. E. Solheim, and R.R. Scheline Metabolism of alkylbenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers Xenobiotica 6 1973 137 150
80. M. Delaforge, P. Janiaud, O. Levi, and J.P. Moritoz Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide diol pathway Xenobiotica 10 1980 737 744
81. J.A. Miller, E.C. Miller, and D.H. Phillips The metabolic activation and carcinogenicity of alkenylbenzenes that occur naturally in many spices H.F. Stich Carcinogens and Mutagens in the Environment vol. I 1982 CRC Press Boca Raton 83 96
82. S.S. Epstein, D. Fujii, J. Andrea, and N. Mantel Carcinogenicity testing of selected food additives by parenteral administration to infant swiss mice Toxicol. Appl. Pharmacol. 16 1970 321 334
83. P. Borchert, J.A. Miller, E.C. Miller, and T.K. Shires 1′-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse Cancer Res. 33 1973 590 600
84. 32P- Postlabelling assay in mice of transplacental DNA damage induced by environmental carcinogens safrole, 4-aminobiphenyl, benzo[a]pyrene Cancer Res. 46 1986 3046 3054
85. S.D. Vesselinovitch, K.V. Rao, and N. Mihailovich Transplacental and lactational carcinogenesis by safrole Cancer Res. 39 1979 4378 4380
86. P. Fritsch, G. de Saint Blanque, and R. Deranche Gastrointestinal absorption in the rat of anisole, trans-anethole, butyl-hydroxyanisole and safrole Food Cosmet. Toxicol. 13 1975 359 363
87. P. Fritsch, Y. Lamboeuf, and G. de Saint Blanquet Effect of anisole, anethole, butyl-hydroxyanisole and safrole on intestinal absorption in the rat Toxicology 4 1975 341 346
88. J.L. Bolton, N.M. Acay, and V. Vukomanovic Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole Chem. Res. Toxicol. 7 1994 443 450
89. J.L. Bolton, E. Comeau, and V. Vukomanovic The influence of 4-alkyl substituents on the formation and reactivity of 2-methoxy-quinone methides: evidence that extended π-conjugation dramatically stabilizes the quinone methide formed from eugenol Chem. Biol. Interact. 95 1995 279 290
90. K.P. Randerath, K.L. Putman, and E. Randerath Flavor constituents in cola drinks induce hepatic DNA adducts in adult and fetal mice Biochem. Biophys. Res. Commun. 192 1993 61 68
91. E.W. Boberg, E.C. Miller, J.A. Miller, A. Poland, and A. Liem Strong evidence from studies with brachimorphic mice and pentachlorophenol that 1′-sulphooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver Cancer Res. 43 1983 5163 5173
92. S.M.F. Jeurissen, J.J.P. Bogaards, H.M. Awad, M.G. Boersma, W. Brand, Y.C. Fiamegos, T.A. van Beek, G.M. Alink, E.J.R. Sudhölter, N.H.P. Cnubben, and I.M.C.M. Rietjens Human cytochrome P450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1′-hydroxysafrole Chem. Res. Toxicol. 17 2004 1245 1250
93. Y.F. Ueng, C.H. Hsieh, M.J. Don, C.W. Chi, and L.K. Ho Identification of the main human cytochrome P450 enzymes involved in safrole 1′- hydroxylation Chem. Res. Toxicol. 17 2004 1151 1156
94. M. Ingelman-Sundberg, M. Oscarson, and R.A. McLellan Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment Trend Pharmacol. Sci. 20 1999 342 349
95. B.J. Roberts, S.E. Shoaf, and B.J. Song Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats Biochem. Pharmacol. 49 1995 1665 1673
96. E. Alexandre, P. David, C. Viollon, P. Wolf, D. Jaeck, A. Azimzadeh, L. Nicod, K. Boudjema, and L. Richert Expression of cytochromes P450 2E1, 3A4 and 1A1/1A2 in growing and confluent human HepG2 hepatoma cells - effect of ethanol Toxicol. In Vitro 13 1999 427 435
97. S. Gerbal-Chaloin, J.-M. Pascussi, L. Pichard-Garcia, M. Daujat, F. Waechter, J.-M. Fabre, N. Carrere, and P. Maurel Induction of CYP2C genes in human hepatocytes in primary culture Drug Metab. Dispos. 29 2001 242 251
98. A.J.M. Walker, and A.J.M. Woodrooffe Cytochrome P450 activity in control and induced long-term cultures of rat hepatocyte spheroids Toxicol. In Vitro 15 2001 713 719
99. Y. Mitsunaga, T. Kubota, A. Ishiguro, Y. Yamada, H. Sasaki, K. Chiba, and T. Iga Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population Mut. Res. 505 2002 83 85
100. U.A. Meyer Pharmacogenetics and adverse drug reactions Lancet 356 2000 1667 1671